Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 27 to Oct. 1, 2021. […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 27 to Oct. 1, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Intranasal Corticosteroids Tied to Less Severe COVID-19 Outcomes
FRIDAY, Oct. 1, 2021 (HealthDay News) — Intranasal corticosteroid therapy is associated with a lower risk for COVID-19-related hospitalization, intensive care unit admission, and death, according to a study recently published in the Journal of Allergy and Clinical Immunology: In Practice.
1 in 4 Parents Say Their Children Have Been Quarantined Since School Started
FRIDAY, Oct. 1, 2021 (HealthDay News) — One-quarter of U.S. parents report that their child has had to quarantine because of possible COVID-19 exposure since school started, a new poll reveals.
Merck to Ask FDA for Emergency Approval of Its New Antiviral Pill for COVID-19
FRIDAY, Oct. 1, 2021 (HealthDay News) — Pharmaceutical giant Merck & Co. said Friday that it will seek federal approval for emergency use of its new antiviral pill molnupiravir after a clinical trial showed the drug halved the risk for hospitalization or death when given to high-risk people shortly after infection with COVID-19.
REGEN-COV Reduces Risk for COVID-19 Hospitalization, Death
FRIDAY, Oct. 1, 2021 (HealthDay News) — For outpatients with COVID-19 and risk factors for severe disease, REGEN-COV reduces the risk for COVID-19-related hospitalization or death from any cause, according to a study published online Sept. 29 in the New England Journal of Medicine.
COVID-19 Deaths Up for Kidney Waitlist Candidates, Transplant Recipients
FRIDAY, Oct. 1, 2021 (HealthDay News) — Among waitlisted candidates and kidney transplant recipients, a considerable proportion of deaths in 2020 were attributed to COVID-19, according to research published online Sept. 29 in the Clinical Journal of the American Society of Nephrology.
Exercise May Improve Child Mental Health During Pandemic
FRIDAY, Oct. 1, 2021 (HealthDay News) — Physical activity and less screen time are associated with better mental health outcomes for children during the pandemic, according to a study published online Oct. 1 in JAMA Network Open.
No Change Found in Pattern of Adverse Events After Third COVID-19 Shot
THURSDAY, Sept. 30, 2021 (HealthDay News) — Safety monitoring indicates that the pattern of adverse reactions after dose 3 of the COVID-19 vaccine is similar to that seen after dose 2, according to research published in the Oct. 1 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Americans Divided on Biden’s COVID-19 Vaccine Mandate, Poll Finds
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths 
.jpeg)
